WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictive (Links to an external site)


A research team, led by scientists at the Center for Clinical Pharmacology at Washington University School of Medicine and the University of Health Sciences & Pharmacy in St. Louis, have altered the chemical properties of fentanyl and the way that it binds to opioid receptors on nerve cells. The goal is to improve the drug’s safety profile without eliminating its ability to alleviate pain.

$33 million to support study comparing anesthetic medications (Links to an external site)

propofol vs. inhaled anesthetic drugs

Funded by a $33 million grant from the Patient-Centered Outcomes Research Institute (PCORI), a new study led by Michael Avidan, MBBCh, of Washington University School of Medicine in St. Louis and Sachin Kheterpal, MD, of the University of Michigan, will compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.

Department celebrates CRNA Class of 2020

CRNA Class of 2020

The Nurse Anesthesia program at the Goldfarb School of Nursing celebrated its Commencement virtually on Saturday, December 19, 2020.

Jonathan Zoller, MD, appointed POD 3 Leader

Jonathan Zoller, MD

Dr. Zoller will work closely with the WUDA and BJH Perioperative leadership in supporting clinical staff to promote safety, quality, and efficiency in perioperative care.

Pratik Sinha, MBChB, PhD, joins department

Pratik Sinha

In addition to pursuing his research, Dr. Sinha will be working clinically and educating residents and fellows in the Barnes-Jewish Hospital ICUs.